Dosimetric impact of organ at risk daily variation during prostate stereotactic ablative radiotherapy.
Lynsey DevlinDavid DoddsAzmat SadozyePhilip McLooneNicholas MacLeodCarolynn LambSuzanne CurrieStefanie ThomsonAileen DufftonPublished in: The British journal of radiology (2020)
OAR variation in prostate SABR using a FFF technique, may cause the treatment DVH to be higher than planned.